Stockholm Science City

Close menu

News

The move to Hagastaden made Atlas Antibodies even stronger

New member of the board: Carl Johan Sundberg

Interdisciplinary collaboration maps the cellular and molecular landscape of childhood diseases

Monthly Perspective

We must think bigger, act faster, and collaborate more closely

New team member at Stockholm Science City

Solution for analyzing DNA-associated diseases in sight

Meet the new Director of Research and Innovation

"Our work helps clients reduce risks in projects and avoid dead ends"

A unique Nordic initiative highlighting the patient's perspective

Alder Therapeutics is developing new cell therapy to prevent blindness